Tag:
Merck KGaA
Latest Headlines
Latest Headlines
Merck & Co. sues Merck KGaA over naming rights in transatlantic tug-of-war
Last October, when Germany's Merck KGaA dropped divisional tags Merck Serono and Merck Millipore to become simply "Merck," it knew it risked increasing confusion between itself and its American rival by the same name. But while the German drugmaker may have been okay with the idea, the New Jersey-based pharma giant wasn't, and now it's lashing out legally to win the moniker for itself.
BioMed X emerges from Merck KGaA alliance armed with bioinformatics tools
BioMed X has begun offering bioinformatics services on the back of its alliance with Merck KGaA. The services are underpinned by tools developed during BioMed X's three-year collaboration with Merck KGaA, during which it advanced computational approaches to the design of highly selective kinase inhibitors.
Merck KGaA JV set to start producing drugs in remote Algerian village
Germany's Merck KGaA has for some years been taking steps to cash in on the growing population in emerging markets of people needing treatment for diabetes and associated conditions, sometimes building plants to make its diabetes treatments locally. Working through a joint venture, a plant is starting production in North Africa.
Importer recalls Sedalmex acetaminophen product made by Merck KGaA in Mexico
In yet another recall of acetaminophen, Midway Importing is recalling nearly 165,000 boxes of Sedalmex. But Midway is not the producer. That is Merck KGaA, which manufactured the pain reliever at a plant in Mexico.
Merck KGaA exits 'sea of sameness' with futuristic rebrand
Merck KGaA has been playing a guessing game. The rules: Look at 6 photographs, each from a pharma company website, and try to figure out which belongs to Merck KGaA. It's a challenge that's been foiling players from both inside and outside the company, the pharma's head of branding and communications strategy, Axel Löber, told FiercePharmaMarketing.
Merck KGaA hopes to spiff up its image with new logo, fewer names
Merck KGaA has a new leadership team in healthcare, and as of Tuesday, a newly named successor to its CEO. Now it's working on a new brand identity.
Dako to develop companion diagnostic for Pfizer and Merck KGaA's joint cancer candidate
Pharma bigwigs Merck KGaA and Pfizer announced they are collaborating with Dako to develop a companion diagnostic to accompany their investigational immune checkpoint inhibiting candidate in the fight against cancer.
Dako to develop companion diagnostic for Pfizer and Merck KGaA's joint cancer candidate
Pharma bigwigs Merck KGaA and Pfizer announced they are collaborating with Dako to develop a companion diagnostic to accompany their investigational immune checkpoint inhibiting candidate in the fight against cancer.
Merck KGaA partner Genea gets CE mark for a pair of IVF technologies
Genea Biomedx partnered its three fertility products in development with Merck KGaA last month. Now it's won a CE mark for two of them: the Gavi automated vitrification instrument and the Geri benchtop incubator.
Merck KGaA's amped-up consumer pitch delivers much-needed sales hike
Sales for Merck KGaA's OTC unit posted a double-digit jump in Q1, and it was no accident. The company has been doubling down on the "consumer" part of "consumer health"--a move it says is paying off.
